Additional file 3: of Safety and efficacy of tofacitinib for up to 9.5â years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study
Autor: | JĂźrgen Wollenhaupt, Eun-Bong Lee, Curtis, Jeffrey, Silverfield, Joel, Ketti Terry, Koshika Soma, Mojcik, Chris, DeMasi, Ryan, Strengholt, Sander, Kwok, Kenneth, Lazariciu, Irina, Lisy Wang, Cohen, Stanley |
---|---|
Rok vydání: | 2019 |
DOI: | 10.6084/m9.figshare.7961651.v1 |
Popis: | Table S2. Patient baseline demographic and disease characteristics. |
Databáze: | OpenAIRE |
Externí odkaz: |